Table 2.

Correlation between serum Hsp70 levels and clinical and laboratory variables (total n = 167, NYHA I–II n = 83, NYHA III–IV n = 84)

Variables		r (p value)
	Total	−0.29 (<0.001)
Left ventricular ejection fraction	NYHA I–II	−0.17 (0.126)
	NYHA III–IV	−0.27 (0.016)
	Total	0.29 (<0.0001)
Serum bilirubin	NYHA I–II	0.28 (0.006)
	NYHA III–IV	0.30 (0.006)
	Total	0.27 (<0.001)
Aspartate aminotransferase	NYHA I–II	0.16 (0.122)
	NYHA III–IV	0.42 (0.0001)
	Total	0.20 (0.009)
Alanine aminotransferase	NYHA I–II	0.17 (0.101)
	NYHA III–IV	0.29 (0.009)
	Total	0.38 (<0.0001)
Gamma-glutamyl-transpeptidase	NYHA I–II	0.22 (0.034)
	NYHA III–IV	0.42 (0.0001)
	Total	0.01 (0.944)
Serum creatinine	NYHA I–II	−0.17 (0.106)
	NYHA III–IV	0.05 (0.647)
	Total	0.06 (0.423)
TNF-alpha	NYHA I–II	−0.07 (0.637)
	NYHA III–IV	0.24 (0.073)
	Total	0.13 (0.119)
IL-6 (n = 138)	NYHA I–II	0.03 (0.792)
	NYHA III–IV	0.16 (0.193)
	Total	0.08 (0.303)
Hemoglobin	NYHA I–II	0.19 (0.071)
	NYHA III–IV	0.07 (0.529)
	Total	0.13 (0.090)
Red cell distribution width (%)	NYHA I–II	0.11 (0.323)
	NYHA III–IV	0.04 (0.703)

Spearman rank correlation coefficients with p values are displayed.

NYHA New York Heart Association, TNF tumour necrosis factor, IL-6 interleukin 6